Filter Results
:
(2,759)
Show Results For
-
All HBS Web
(2,759)
- People (12)
- News (696)
- Research (1,515)
- Events (2)
- Multimedia (20)
- Faculty Publications (622)
Show Results For
-
All HBS Web
(2,759)
- People (12)
- News (696)
- Research (1,515)
- Events (2)
- Multimedia (20)
- Faculty Publications (622)
- 23 Oct 2015
- News
The Mayo Clinic Model for Running a Value-Improvement Program
- 2017
- Working Paper
Why and How Investors Use ESG Information: Evidence from a Global Survey
Using survey data from a sample of senior investment professionals from mainstream (i.e., not SRI funds) investment organizations, we provide insights into why and how investors use reported environmental, social, and governance (ESG) information. The primary reason...
View Details
Keywords:
Investment Management;
Sustainability;
ESG;
ESG (Environmental, Social, Governance) Performance;
Investment Fund;
Investment Strategy;
Corporate Accountability;
Activist Shareholder;
Engagement;
Environment;
Climate Change;
Customers;
Customer Satisfaction;
Employee Engagement;
Global Warming;
Investment;
Decision Making;
Environmental Sustainability;
Performance Expectations
Serafeim, Georgios. "Why and How Investors Use ESG Information: Evidence from a Global Survey." Harvard Business School Working Paper, No. 17-079, February 2017.
Leemore S. Dafny
Leemore Dafny is the Bruce V. Rauner Professor of Business Administration and the Mary Ellen Jay and Jeffrey Jay Fellow at the Harvard Business School, and Professor of Public Policy at the Harvard Kennedy School. Dafny is an... View Details
Keywords:
health care
- March 2000
- Case
Medscape
By: Richard M.J. Bohmer and Lisa Shapiro Strovink
Medscape is a health care Web site that focuses on delivering high-quality information to health providers and consumers. This case describes Medscape's formation and business model and asks, How is this model unique and is it sustainable?
View Details
Keywords:
Business Model;
Customer Focus and Relationships;
Service Delivery;
Web Sites;
Information Industry
Bohmer, Richard M.J., and Lisa Shapiro Strovink. "Medscape." Harvard Business School Case 600-056, March 2000.
- 03 Feb 2015
- Working Paper Summaries
Regulator Leniency and Mispricing in Beneficent Nonprofits
- November 1992 (Revised July 1993)
- Case
Fischer Francis Trees & Watts
By: Erik R. Sirri
Fisher Francis Trees & Watts is a New York fixed-income investment management firm. A portfolio manager needs to purchase $375 million of 5-year notes at the Treasury auction. Unlike previous auctions, however, this is the first time the Treasury will auction the notes...
View Details
Sirri, Erik R. "Fischer Francis Trees & Watts." Harvard Business School Case 293-056, November 1992. (Revised July 1993.)
- Teaching
Overview
Course Requirements
Students are required to prepare a business plan, which employs the framework of this course, to explore an entrepreneurial opportunity in health care, and to evaluate their classmates' plans.
Career Focus
For... View Details
Students are required to prepare a business plan, which employs the framework of this course, to explore an entrepreneurial opportunity in health care, and to evaluate their classmates' plans.
Career Focus
For... View Details
- March 2007 (Revised February 2010)
- Case
Fabindia Overseas Pvt. Ltd.
By: Mukti Khaire and Prabakar (PK) Kothandaraman
Fabindia is a for-profit Indian retail company with the stated mission of providing employment to weavers and traditional handicraft artisans in rural India. Established in 1960 as an exporter of home furnishings, Fabindia has grown as a consumer-facing retailer of...
View Details
Keywords:
Business Model;
For-Profit Firms;
Growth and Development Strategy;
Supply Chain;
Mission and Purpose;
Expansion;
Retail Industry;
India
Khaire, Mukti, and Prabakar (PK) Kothandaraman. "Fabindia Overseas Pvt. Ltd." Harvard Business School Case 807-113, March 2007. (Revised February 2010.)
- March 2015
- Case
Novartis Pharmaceuticals Corp: Redefining Success in the U.S. (A)
By: Gautam Mukunda, Thomas DeLong and Aldo Sesia
Over the course of a tumultuous weekend in April 2010, André Wyss was put in charge of Novartis Pharmaceuticals Corporation (NPC), the U.S. sales and marketing subsidiary of Novartis Pharma AG. He was brought in at a critical point in the organization's evolution with...
View Details
Keywords:
LEAD;
Talent Management;
Leadership And Change Management;
Change Management;
Organizational Change and Adaptation;
Restructuring;
Pharmaceutical Industry;
United States
Mukunda, Gautam, Thomas DeLong, and Aldo Sesia. "Novartis Pharmaceuticals Corp: Redefining Success in the U.S. (A)." Harvard Business School Case 415-013, March 2015.
- October 2022
- Article
It’s Not Just the Prices: Time-Driven Activity-Based Costing for Initiation of Veno-Venous Extracorporeal Membrane Oxygenation at Three International Sites—A Case Review
By: Michael Nurok, Vin Pellegrino, Marc Pineton de Chambrun, Jonathan Warsh, Meredith Young, Erik Dong, Neil Parrish, Syed Shehab, Alain Combes and Robert S. Kaplan
The United States spends more for intensive care units (ICUs) than do other high-income countries. We used time-driven activity-based costing (TDABC) to analyze ICU costs for initiation of extracorporeal membrane oxygenation (ECMO) for respiratory failure to estimate...
View Details
Keywords:
Healthcare;
Cost;
Time-Driven ABC;
Health Care and Treatment;
Cost Management;
Activity Based Costing and Management;
Health Industry
Nurok, Michael, Vin Pellegrino, Marc Pineton de Chambrun, Jonathan Warsh, Meredith Young, Erik Dong, Neil Parrish, Syed Shehab, Alain Combes, and Robert S. Kaplan. "It’s Not Just the Prices: Time-Driven Activity-Based Costing for Initiation of Veno-Venous Extracorporeal Membrane Oxygenation at Three International Sites—A Case Review." Anesthesia & Analgesia 135, no. 4 (October 2022): 711–718.
- July 2003 (Revised August 2003)
- Case
Global Healthcare Exchange
By: Lynda M. Applegate and Jamie Ladge
Founded in March 2000 at the height of the dot-com bubble, Global Healthcare Exchange (GHX) was one of 90 online marketplaces in the health care industry. The company's founders were among the largest suppliers in the industry, including Johnson & Johnson, GE Medical,...
View Details
Keywords:
Mergers and Acquisitions;
Entrepreneurship;
Price;
Leadership;
Growth and Development Strategy;
Supply and Industry;
Organizational Design;
Expansion;
Internet and the Web;
Valuation;
Health Industry
Applegate, Lynda M., and Jamie Ladge. "Global Healthcare Exchange." Harvard Business School Case 804-002, July 2003. (Revised August 2003.)
- 2016
- Chapter
Dishonesty Explained: What Leads Moral People To Act Immorally
By: F. Gino and D. Ariely
The last two decades have witnessed what seems to be an increasing number of cases of dishonesty, from corporate corruption and employee misconduct to questionable behaviors during the financial crisis and individual acts of unethical behavior in many spheres of...
View Details
Gino, F., and D. Ariely. "Dishonesty Explained: What Leads Moral People To Act Immorally." In The Social Psychology of Good and Evil. 2nd ed. Edited by Arthur G. Miller. New York: Guilford Press, 2016.
- Research Summary
Behavioral Hazard and Public Policy
It is well recognized that people overuse low-value medical care due to moral hazard—because copays are lower than costs. Now Professor Schwartzstein has introduced the concept of “behavioral hazard” to explain the opposite: people underuse high-value care because... View Details
Joey Ryu
Joey (Won Jung) Ryu is a doctoral student in the Strategy unit at Harvard Business School. Her primary interests are strategic management, economics of innovation and entrepreneurship. Prior to joining HBS, Joey recieved her master's degree from Cornell University...
View Details
- 2019
- Book
Patient Capital: The Challenges and Promises of Long-Term Investing
By: Victoria Ivashina and Josh Lerner
There has never been a greater need for long-term investments. And it is increasingly unlikely that the public sector will be willing or able to fill the gap. Those best positioned to address the long-run needs are likely to be the pools of capital in the hands of...
View Details
Keywords:
Long-term Investing;
Large Investors;
Capital;
Investment;
Strategic Planning;
Problems and Challenges;
Opportunities;
Society
Ivashina, Victoria, and Josh Lerner. Patient Capital: The Challenges and Promises of Long-Term Investing. First ed. Princeton, NJ: Princeton University Press, 2019.
- 2010
- Book
Winning in Emerging Markets: A Road Map for Strategy and Execution
By: Tarun Khanna, Krishna G. Palepu and Richard Bullock
The best way to select emerging markets to exploit is to evaluate their size or growth potential, right? Not according to Krishna Palepu and Tarun Khanna. In 'Winning in Emerging Markets,' these leading scholars on the subject present a decidedly different framework...
View Details
Keywords:
Developing Countries and Economies;
Management Analysis, Tools, and Techniques;
Emerging Markets;
Organizations;
Opportunities;
Business Strategy
Khanna, Tarun, Krishna G. Palepu, and Richard Bullock. Winning in Emerging Markets: A Road Map for Strategy and Execution. Boston: Harvard Business Press, 2010.
- April 2021
- Article
Utilizing Time-driven Activity-based Costing to Determine Open Radical Cystectomy and Ileal Conduit Surgical Episode Cost Drivers
By: Janet Baack Kukreja, Mohamed A. Seif, Marissa W. Merry, James R. Incalcaterra, Ashish M. Kamat, Colin P. Dinney, Jay B. Shah, Thomas W. Feeley and Neema Navai
Objectives
Patients undergoing radical cystectomy represent a particularly resource-intensive patient population. Time-driven activity based costing (TDABC) assigns time to events and then costs are based on the people involved in providing care for specific... View Details
Patients undergoing radical cystectomy represent a particularly resource-intensive patient population. Time-driven activity based costing (TDABC) assigns time to events and then costs are based on the people involved in providing care for specific... View Details
Keywords:
Time-Driven Activity-Based Costing;
Value-based Healthcare;
Health Care and Treatment;
Cost;
Cost vs Benefits;
Analysis
Kukreja, Janet Baack, Mohamed A. Seif, Marissa W. Merry, James R. Incalcaterra, Ashish M. Kamat, Colin P. Dinney, Jay B. Shah, Thomas W. Feeley, and Neema Navai. "Utilizing Time-driven Activity-based Costing to Determine Open Radical Cystectomy and Ileal Conduit Surgical Episode Cost Drivers." Urologic Oncology: Seminars and Original Investigations 39, no. 4 (April 2021).
- Article
Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry
By: Leemore S. Dafny, Christopher Ody and Matt Schmitt
The analogy between value-based purchasing in pharmaceuticals and the new frontier of alternative payment models for health care providers is relatively straightforward. Insurers are increasingly demanding steep discounts from providers in exchange for inclusion in...
View Details
Keywords:
Drug Copayment Coupons;
Prescription Drug Policy;
Health Care and Treatment;
Insurance;
Cost;
Policy;
Pharmaceutical Industry
Dafny, Leemore S., Christopher Ody, and Matt Schmitt. "Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry." New England Journal of Medicine 375, no. 21 (November 24, 2016): 2013–2015.
- August 23, 2018
- Article
Using a New EHR System to Increase Patient Engagement, Improve Efficiency, and Decrease Cost
By: Katy French, Barbra Bryce Speer, Alexis B. Guzman, Tayab Andrabi, Iris Recinos, Keith A. Shook, James R. Incalcaterra, John C. Frenzel and Thomas W. Feeley
Patients and providers are frustrated with seemingly endless data entry. We used our patients’ vested interest in their own health care by actively engaging them in the entry of their own medical information into the EHR. Prior to the implementation of the new EHR we...
View Details
Keywords:
Health Care and Treatment;
Analytics and Data Science;
Performance Efficiency;
Cost Management
French, Katy, Barbra Bryce Speer, Alexis B. Guzman, Tayab Andrabi, Iris Recinos, Keith A. Shook, James R. Incalcaterra, John C. Frenzel, and Thomas W. Feeley. "Using a New EHR System to Increase Patient Engagement, Improve Efficiency, and Decrease Cost." NEJM Catalyst (August 23, 2018).